Brevan Howard Capital Management’s 89bio ETNB Stock Holding History

Brevan Howard Capital Management’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11,163	Closed	-$164K	–	1939
2025 Q3	$164K	Sell	11,163 -34,802	-76%	-$355K	﹤0.01%	1796
2025 Q2	$451K	Buy	+45,965	New	+$381K	﹤0.01%	1396
2024 Q4	–	Sell	-14,259	Closed	-$106K	–	1157
2024 Q3	$106K	Sell	14,259 -9,741	-41%	-$81.9K	﹤0.01%	1070
2024 Q2	$192K	Buy	24,000 +11,719	+95%	+$105K	﹤0.01%	901
2024 Q1	$143K	Buy	+12,281	New	+$136K	﹤0.01%	854

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Brevan Howard Capital Management's ETNB Position: Q4 2025 in Review

Brevan Howard Capital Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 11,163 shares — an estimated $164K sold.

Brevan Howard Capital Management first reported a position in ETNB in Q1 2024 and held it in 5 quarters. The position peaked at $451K in Q2 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Brevan Howard Capital Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Brevan Howard Capital Management sold 11,163 89bio shares in Q4 2025, an estimated $164K.
Brevan Howard Capital Management first reported a position in 89bio in Q1 2024 and held it in 5 quarters.
Brevan Howard Capital Management's 89bio position peaked at $451K in Q2 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Brevan Howard Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.